5-hydroxytryptophan has been researched along with fluvoxamine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (57.14) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Handley, SL; Njung'e, K | 1 |
| Calanchini, B; Pöldinger, W; Schwarz, W | 1 |
| Asberg, M; Eriksson, B; Mårtensson, B; Träskman-Bendz, L; Wägner, A | 1 |
| Melzacka, M; Pawłowski, L | 1 |
| den Boer, JA; Kahn, RS; Westenberg, HG | 1 |
| Blansjaar, BA; Dijken, WA; Haffmans, J; Kamp, JS; Kramer, HJ; Nolen, WA; van de Putte, JJ | 1 |
| Dijken, WA; Kamp, JS; Nolen, WA; van de Putte, JJ | 1 |
| Cella, S; Cocchi, D; Locatelli, V; Müller, EE; Novelli, A; Penalva, A | 1 |
| Genazzani, AR; Müller, EE; Penalva, A; Petraglia, F | 1 |
| Maj, J; Rogóz, Z; Skuza, G | 1 |
| Hyttel, J; Sánchez, C | 1 |
| Brieaddy, L; Cooper, B; Ferris, RM; Hollingsworth, E; Mehta, N; Rigdon, G; Soroko, F; Wang, C; Wastila, W | 1 |
| Gibert-Rahola, J; Mico, JA; Rojas-Corrales, MO | 1 |
| Akhondzadeh, S; Alikhani, R; Aqamolaei, A; Ghaffari, S; Jalilevand, S; Mortazavi, SH; Mortezaei, A; Mousavi, SB; Naderi, S; Sadri, A; Sahebolzamani, E; Shalbafan, MR; Shamabadi, A; Yousefzadeh, F | 1 |
1 review(s) available for 5-hydroxytryptophan and fluvoxamine
| Article | Year |
|---|---|
Therapeutic effects of serotonin uptake inhibitors in depression.
Topics: 5-Hydroxytryptophan; Alanine; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Imipramine; Oximes; Paroxetine; Piperidines; Propylamines; Serotonin; Serotonin Antagonists; Trazodone; Zimeldine | 1986 |
5 trial(s) available for 5-hydroxytryptophan and fluvoxamine
| Article | Year |
|---|---|
A functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine.
Topics: 5-Hydroxytryptophan; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Brain; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Male; Middle Aged; Oximes; Psychiatric Status Rating Scales; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1991 |
Psychopharmacology of anxiety disorders: on the role of serotonin in the treatment of anxiety states and phobic disorders.
Topics: 5-Hydroxytryptophan; Anxiety Disorders; Clomipramine; Female; Fluvoxamine; Humans; Male; Oximes; Serotonin | 1987 |
Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine.
Topics: 5-Hydroxytryptophan; Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Female; Fluvoxamine; Humans; Male; Maprotiline; Middle Aged; Nomifensine; Oximes; Psychological Tests; Tranylcypromine | 1988 |
L-5HTP in depression resistant to re-uptake inhibitors. An open comparative study with tranylcypromine.
Topics: 5-Hydroxytryptophan; Adult; Aged; Carbidopa; Clinical Trials as Topic; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Fluvoxamine; Follow-Up Studies; Humans; Maprotiline; Middle Aged; Oximes; Random Allocation; Serotonin Antagonists; Stereoisomerism; Tranylcypromine | 1985 |
5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control.
Topics: 5-Hydroxytryptophan; Adult; Double-Blind Method; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Treatment Outcome; Young Adult | 2020 |
8 other study(ies) available for 5-hydroxytryptophan and fluvoxamine
| Article | Year |
|---|---|
Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents.
Topics: 5-Hydroxytryptophan; Amphetamines; Animals; Anti-Anxiety Agents; Behavior, Animal; Dose-Response Relationship, Drug; Drug Interactions; Female; Fenfluramine; Fluvoxamine; Mice; Motor Activity; Piperazines; Serotonin; Serotonin Antagonists; Zimeldine | 1991 |
Inhibition of head twitch response to quipazine in rats by chronic amitriptyline but not fluvoxamine or citalopram.
Topics: 5-Hydroxytryptophan; Amitriptyline; Animals; Brain; Chromatography, Gas; Citalopram; Fluvoxamine; Male; Oximes; Propylamines; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Time Factors | 1986 |
Neuroendocrine studies with fluvoxamine: animal data.
Topics: 5-Hydroxytryptophan; Animals; Endocrine Glands; Endorphins; Female; Fluvoxamine; Luteinizing Hormone; Male; Neurotransmitter Agents; Oximes; Prolactin; Rats; Rats, Inbred Strains; Serotonin Antagonists; Time Factors | 1983 |
Stimulation of beta-endorphin and beta-lipotropin release from the anterior but not the neurointermediate pituitary lobe in the rat after acute administration of serotonin-acting drugs.
Topics: 5-Hydroxytryptophan; Animals; beta-Endorphin; beta-Lipotropin; Endorphins; Fluvoxamine; Male; Oximes; Pituitary Gland; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin | 1982 |
Fluvoxamine, a new antidepressant drug, fails to show antiserotonin activity.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Body Temperature; Fluvoxamine; Male; Mice; Oximes; Rats; Rats, Inbred Strains; Reflex; Serotonin Antagonists; Spinal Cord; Tryptamines | 1982 |
Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
Topics: 1-Naphthylamine; 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Aggression; Analysis of Variance; Animals; Behavior, Animal; Brain; Citalopram; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Fluvoxamine; Male; Mice; Paroxetine; Penbutolol; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Sertraline; Synaptosomes | 1994 |
Pharmacological properties of 403U76, a new chemical class of 5-hydroxytryptamine- and noradrenaline-reuptake inhibitor.
Topics: 5-Hydroxytryptophan; Adrenergic Uptake Inhibitors; Animals; Animals, Newborn; Benzyl Alcohols; Binding, Competitive; Dogs; Electrophysiology; Fluoxetine; Fluvoxamine; Hemodynamics; Imipramine; Male; Mice; Neurons; Norepinephrine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Species Specificity; Synaptic Transmission; Tetrabenazine; Vocalization, Animal | 1995 |
Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior.
Topics: 5-Hydroxytryptophan; Analgesics, Opioid; Animals; Clozapine; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Fluvoxamine; Indophenol; Levorphanol; Male; Methadone; Mice; Morphine; Naloxone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Piperazines; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Stereotyped Behavior; Tics; Tourette Syndrome; Tramadol; Triazoles | 2007 |